Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Maman Ibrahim - Why Pharma Boards Confuse Scenario Models With Risk Measurements
Why Pharma Boards Confuse Scenario Models With Risk Measurements
Forbes

Maman Ibrahim is a cyber and digital risk executive, helping boards, CRO, CIO, and CISO turn risk work into decisions, delivery, and proof. A large number can change the weather in a boardroom. The chair looks up. The CFO stops scrolling. Someone…

newstatesman.com - Nick Dearden - The US pharma deal is a crime against UK healthcare
The US pharma deal is a crime against UK healthcare
The Newstatesman

This week, we took the first step in a legal challenge which we hope will force a change of heart in government towards its pharma “deal” with the United States. Signed with Donald Trump in December, Keir Starmer heralded the…

nutraingredients.com - Sirio Pharma eyes Australia's gummy supplement market with TGA-compliant range
Sirio Pharma eyes Australia's gummy supplement market with TGA-compliant range
NutraIngredients.com

Sirio Pharma is targeting growth in Australia's gummy supplement market with the launch of a range of Therapeutic Goods Administration (TGA) compliant products.

newswire.ca - Corporation JAMP Pharma - Orimed Pharma Expands PrLuxa-D™ Portfolio to Enhance Vitamin D Treatment Options in Canada
Orimed Pharma Expands PrLuxa-D™ Portfolio to Enhance Vitamin D Treatment Options in Canada
CNW

Orimed Pharma, an affiliate of the JAMP Pharma Group, is expanding the Luxa-D portfolio with new strengths of vitamin D: 5 000, 10 000, 25 000 and 50 000 International Units (IU) These new formulations offer additional dosage options in the…

prospect.org - Susanna Beiser - Can You Support Medicare for All and Take Money From Big Pharma?
Can You Support Medicare for All and Take Money From Big Pharma?
The American Prospect

The 2026 midterm season has so far been marked by the cost-of-living crisis and a desire to bring in a new guard of spunkier, younger politicians who will fight President Trump. In Colorado's First Congressional District, which includes Denver and…

247wallst.com - Omor Ibne Ehsan - Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
24/7 Wall St

iShares U.S. Pharmaceuticals ETF (IHE) returned 38% over twelve months to $89 despite Trump's MFN drug pricing order, driven by Eli Lilly (LLY) and AbbVie (ABBV) pipeline catalysts, but concentration risk is acute with Johnson & Johnson and Eli…

marketbeat.com - Chris Markoch - Mirum Pharma: A Rare Disease Growth Story to Watch
Mirum Pharma: A Rare Disease Growth Story to Watch
MarketBeat

Mirum Pharmaceuticals NASDAQ: MIRM is a late-stage biotechnology company that is making significant progress toward its mission to combat rare diseases with no or limited treatment options. Mirum recently reported its Q1 2026 earnings, headlined by…

marketbeat.com - Royalty Pharma PLC $RPRX Shares Acquired by Cullen Frost Bankers Inc.
Royalty Pharma PLC $RPRX Shares Acquired by Cullen Frost Bankers Inc.
MarketBeat

Cullen Frost Bankers Inc. lifted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund…

marketbeat.com - 49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG
49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG
MarketBeat

Partners Group Holding AG bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 49,855 shares of the…

marketbeat.com - Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX
Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX
MarketBeat

Marathon Asset Management Ltd reduced its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned…

marketbeat.com - Thrivent Financial for Lutherans Acquires 22,015 Shares of Royalty Pharma PLC $RPRX
Thrivent Financial for Lutherans Acquires 22,015 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Thrivent Financial for Lutherans lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 233,320 shares of the…

marketbeat.com - Atle Fund Management AB Sells 33,426 Shares of BridgeBio Pharma, Inc. $BBIO
Atle Fund Management AB Sells 33,426 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Atle Fund Management AB decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 19.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…

zerohedge.com - Tyler Durden - UK COVID Inquiry's Endorsement Of Censorship Sets Chilling Precedent
UK COVID Inquiry's Endorsement Of Censorship Sets Chilling Precedent
Zero Hedge

According to the UK's Covid Inquiry, whose fourth report was published in April, there was “in principle, nothing unlawful or inappropriate in the government monitoring publicly available social media to identify potential trends in…

thehindu.com - The Hindu Bureau - Kurnool police book YSRCP youth leader for allegedly defaming Industries Minister
Kurnool police book YSRCP youth leader for allegedly defaming Industries Minister
The Hindu

The Kurnool police on Tuesday registered a case against YSR Congress Party (YSRCP) youth leader Byreddy Siddharth Reddy for allegedly insulting and harming the reputation of Industries and Commerce Minister T.G. Bharath Gupta. Mr. Siddharth Reddy…

republicworld.com - Nitin Waghela - Stock Market Opening Bell: Sensex Fell 0.57%, Nifty 50 Plummeted 0.68% - Check Key Triggers
Stock Market Opening Bell: Sensex Fell 0.57%, Nifty 50 Plummeted 0.68% - Check Key Triggers
Republic World

Stock Market Opening Bell: The Indian stock market benchmark indices, Sensex and Nifty 50 witnessed a gap down opening on, amid weak cues from global markets and concerns linked to rising inflation and elevated bond yields. While Nifty 50 declined…

Receive a Daily briefing on Pharma Industry News

Get Started